This document is an email thread among Federal Bureau of Prisons (BOP) technicians and specialists occurring between August 8 and August 12, 2019. The discussion concerns technical failures and opinions regarding the NICEVision camera system, with a technician at FCI Otisville reporting a 'Database Error' and inability to reach support (Justin Houston). This conversation occurs simultaneously with the death of Jeffrey Epstein in BOP custody (August 10, 2019), highlighting systemic issues with camera software (NICEVision) and tech support availability within the bureau at that specific time.
This document is a single page from a participant list for the World Economic Forum Annual Meeting held in 2011. It lists attendees alphabetically by surname (starting with 'I' and 'J'), detailing their full name, job title, organization, and country of origin. The list includes high-profile figures from global business, media, academia, and government, such as David Ignatius (Washington Post), Anshu Jain (Deutsche Bank), and Kate James (Bill & Melinda Gates Foundation). The document bears a House Oversight Committee Bates stamp (HOUSE_OVERSIGHT_017081).
This document is a page from the attendee list of the World Economic Forum Annual Meeting 2011. It lists high-profile individuals alphabetically from 'E' to 'F', including their roles, organizations, and countries of origin. Notably, the document includes a 'David R. Epstein' of Novartis AG, who is a pharmaceutical executive and not the financier Jeffrey Epstein, despite the shared surname.
This document is a page from the participant directory of the World Economic Forum Annual Meeting 2011, bearing the Bates stamp HOUSE_OVERSIGHT_017070. It lists high-profile attendees including business executives (Michael Dell, Aliko Dangote), academic leaders (John J. DeGioia), government officials, and celebrities (Robert De Niro), detailing their roles, organizations, and countries of origin. The document is likely part of a larger production of documents provided to the House Oversight Committee.
Discussion 0
No comments yet
Be the first to share your thoughts on this epstein entity